Cover Image
Market Research Report

Asia Pacific 3D Cell Culture Market Forecast 2019-2027

Published by Inkwood Research Product code 910166
Published Content info 104 Pages
Delivery time: 2-3 business days
Price
Back to Top
Asia Pacific 3D Cell Culture Market Forecast 2019-2027
Published: September 6, 2019 Content info: 104 Pages
Description

KEY FINDINGS

The Asia Pacific 3D cell culture market is estimated to grow the fastest at a CAGR of 12.93% during the forecast period. The new entrants in the market, the existing population and the resultant number of affected people, developments in infrastructure, etc. are the factors expected to influence the growth of the market.

MARKET INSIGHTS

The Asia Pacific market is assessed with regards to the regions, such as China, India, South Korea, Australia, Japan, and the Rest of Asia Pacific. The active involvement of government, technological developments, developing markets, rising demand of D culture in organ transplantation, etc. are the factors expected to drive the Asia Pacific 3D cell culture market. The limited data availability, as a result of restricted research, poses a threat to the growth of the market. However, the focus on R&D processes across various countries in the Asia Pacific region is expected to curb this challenge and aid in the growth of the market.

COMPETITIVE INSIGHTS

The investment by the key players in the market has led to the emergence of opportunities with regards to 3D cell culture market. Some of the key players in the market are PromoCell GmbH, Insphero, GE Healthcare, Nano3D Biosciences Inc., Merck KGaA, Lonza Group AG, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 26682

Table of contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. SCAFFOLD FREE IS THE FASTEST GROWING 3D CELL CULTURE TECHNOLOGY
    • 3.2.2. STEM CELL RESEARCH IS THE WIDELY USED APPLICATION
    • 3.2.3. BIOTECHNOLOGY AND PHARMACEUTICAL ORGANIZATIONS ARE THE MAJOR END USERS
    • 3.2.4. REAGENTS AND CONSUMABLES ARE THE MAJOR USED COMPONENTS

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. GROWING DEMAND FOR 3D CELL CULTURE PLATFORMS
    • 4.2.2. TECHNOLOGICAL ADVANCEMENT
    • 4.2.3. INCREASED FOCUS ON THE REGENERATIVE MEDICINE
    • 4.2.4. RISING ASIA PACIFIC R&D INVESTMENTS IN CELL BASED RESEARCH
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. EXPENSES ASSOCIATED WITH THE IMPLEMENTATION OF 3D CELL CULTURE
    • 4.3.2. LACK OF SKILLED PROFESSIONALS
    • 4.3.3. LACK OF CONSISTENCY IN RESULTS
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. USAGE OF THE 3D CULTURE IN DRUG SCREENING AND ORGAN TRANSPLANTATION
    • 4.4.2. RISE IN THE PREVALENCE RATE OF CANCER
  • 4.5. MARKET CHALLENGES
    • 4.5.1. CHALLENGES ASSOCIATED WITH DEVELOPING OPTIMIZED 3D CELL CULTURE
    • 4.5.2. LIMITED DATA AVAILABILITY DUE TO RESTRICTED RESEARCH ON CELL CULTURE

5. MARKET BY TECHNOLOGY

  • 5.1. SCAFFOLD BASED
    • 5.1.1. HYDROGELS
    • 5.1.2. POLYMERIC SCAFFOLDS
    • 5.1.3. MICROPATTERNED SURFACE MICROPLATES
  • 5.2. SCAFFOLD FREE
    • 5.2.1. HANGING DROP MICROPLATES
    • 5.2.2. SPHEROID MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA) COATING
    • 5.2.3. MICROFLUIDIC 3D CELL CULTURE
    • 5.2.4. MAGNETIC LEVITATIONS & 3D BIOPRINTING
  • 5.3. 3D BIOREACTORS

6. MARKET BY APPLICATION

  • 6.1. CANCER
  • 6.2. TISSUE ENGINEERING & IMMUNOHISTOCHEMISTRY
  • 6.3. DRUG DEVELOPMENT
  • 6.4. STEM CELL RESEARCH
  • 6.5. OTHER APPLICATION

7. MARKET BY END-USER

  • 7.1. BIOTECHNOLOGY AND PHARMACEUTICAL ORGANIZATIONS
  • 7.2. RESEARCH LABORATORIES AND INSTITUTES
  • 7.3. HOSPITALS AND DIAGNOSTIC CENTERS
  • 7.4. OTHER END USER

8. MARKET BY COMPONENT

  • 8.1. MEDIA
  • 8.2. REAGENTS AND CONSUMABLES

9. KEY ANALYTICS

  • 9.1. PORTER'S FIVE FORCES MODEL
    • 9.1.1. THREAT OF NEW ENTRANTS
    • 9.1.2. THREAT OF SUBSTITUTE
    • 9.1.3. BARGAINING POWER OF BUYERS
    • 9.1.4. BARGAINING POWER OF SUPPLIERS
    • 9.1.5. THREAT OF COMPETITIVE RIVALRY
  • 9.2. POLITICAL & LEGAL, ECONOMIC, AND TECHNOLOGICAL ANALYSIS
  • 9.3. REGULATORY FRAMEWORK
  • 9.4. OPPORTUNITY MATRIX

10. GEOGRAPHICAL ANALYSIS

  • 10.1. ASIA PACIFIC
    • 10.1.1. JAPAN
    • 10.1.2. CHINA
    • 10.1.3. INDIA
    • 10.1.4. AUSTRALIA
    • 10.1.5. SOUTH KOREA
    • 10.1.6. REST OF ASIA PACIFIC

11. COMPANY PROFILES

  • 11.1. 3D BIOTEK LLC
  • 11.2. BECTON DICKINSON AND COMPANY
  • 11.3. CORNING INC.
  • 11.4. EMULATE
  • 11.5. GE HEALTHCARE
  • 11.6. INSPHERO
  • 11.7. LONZA GROUP AG
  • 11.8. MERCK KGAA
  • 11.9. NANO3D BIOSCIENCES, INC.
  • 11.10. PROMOCELL GMBH
  • 11.11. TECAN TRADING AG.
  • 11.12. THERMO FISHER SCIENTIFIC INC.
  • 11.13. VWR INTERNATIONAL, LLC

LIST OF TABLES

  • TABLE 1 ASIA PACIFIC 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
  • TABLE 2 ASIA PACIFIC 3D CELL CULTURE MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 3 ASIA PACIFIC SCAFFOLD BASED MARKET, 2019-2027 ($ MILLION)
  • TABLE 4 ASIA PACIFIC SCAFFOLD BASED MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 5 ASIA PACIFIC HYDROGELS MARKET, 2019-2027 ($ MILLION)
  • TABLE 6 ASIA PACIFIC POLYMERIC SCAFFOLDS MARKET, 2019-2027 ($ MILLION)
  • TABLE 7 ASIA PACIFIC MICROPATTERNED SURFACE MICROPLATES MARKET, 2019-2027 ($ MILLION)
  • TABLE 8 ASIA PACIFIC SCAFFOLD FREE MARKET, 2019-2027 ($ MILLION)
  • TABLE 9 ASIA PACIFIC SCAFFOLD FREE MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 10 ASIA PACIFIC HANGING DROP MICROPLATES MARKET, 2019-2027 ($ MILLION)
  • TABLE 11 ASIA PACIFIC SPHEROID MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA) COATING MARKET, 2019-2027 ($ MILLION)
  • TABLE 12 ASIA PACIFIC MICROFLUIDIC 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
  • TABLE 13 ASIA PACIFIC MAGNETIC LEVITATIONS & 3D BIOPRINTING MARKET, 2019-2027 ($ MILLION)
  • TABLE 14 ASIA PACIFIC 3D BIOREACTORS MARKET, 2019-2027 ($ MILLION)
  • TABLE 15 ASIA PACIFIC 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 16 ASIA PACIFIC CANCER MARKET, 2019-2027 ($ MILLION)
  • TABLE 17 ASIA PACIFIC TISSUE ENGINEERING & IMMUNOHISTOCHEMISTRY MARKET, 2019-2027 ($ MILLION)
  • TABLE 18 ASIA PACIFIC DRUG DEVELOPMENT MARKET, 2019-2027 ($ MILLION)
  • TABLE 19 ASIA PACIFIC STEM CELL RESEARCH MARKET, 2019-2027 ($ MILLION)
  • TABLE 20 ASIA PACIFIC OTHER APPLICATION MARKET, 2019-2027 ($ MILLION)
  • TABLE 21 ASIA PACIFIC 3D CELL CULTURE MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 22 ASIA PACIFIC BIOTECHNOLOGY AND PHARMACEUTICAL ORGANIZATIONS MARKET, 2019-2027 ($ MILLION)
  • TABLE 23 ASIA PACIFIC RESEARCH LABORATORIES AND INSTITUTES MARKET, 2019-2027 ($ MILLION)
  • TABLE 24 ASIA PACIFIC HOSPITALS AND DIAGNOSTIC CENTERS MARKET, 2019-2027 ($ MILLION)
  • TABLE 25 ASIA PACIFIC OTHER END USER MARKET, 2019-2027 ($ MILLION)
  • TABLE 26 ASIA PACIFIC 3D CELL CULTURE MARKET, BY COMPONENT, 2019-2027 ($ MILLION)
  • TABLE 27 USAGE OF MEDIA IN DIFFERENT STAGES OF ORGANOIDS FORMATION
  • TABLE 28 ASIA PACIFIC MEDIA MARKET, 2019-2027 ($ MILLION)
  • TABLE 29 ASIA PACIFIC REAGENTS AND CONSUMABLES MARKET, 2019-2027 ($ MILLION)
  • TABLE 30 ASIA PACIFIC 3D CELL CULTURE MARKET, BY COUNTRY, 2019-2027 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1 ASIA PACIFIC 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
  • FIGURE 2 ASIA PACIFIC 3D CELL CULTURE MARKET SHARE, BY TECHNOLOGY 2018 & 2027 (%)
  • FIGURE 3 ASIA PACIFIC 3D CELL CULTURE MARKET, BY SCAFFOLD BASED, 2019-2027 ($ MILLION)
  • FIGURE 4 ASIA PACIFIC 3D CELL CULTURE MARKET, BY HYDROGELS, 2019-2027 ($ MILLION)
  • FIGURE 5 ASIA PACIFIC 3D CELL CULTURE MARKET, BY POLYMERIC SCAFFOLDS, 2019-2027 ($ MILLION)
  • FIGURE 6 ASIA PACIFIC 3D CELL CULTURE MARKET, BY MICROPATTERNED SURFACE MICROPLATES, 2019-2027 ($ MILLION)
  • FIGURE 7 ASIA PACIFIC 3D CELL CULTURE MARKET, BY SCAFFOLD FREE, 2019-2027 ($ MILLION)
  • FIGURE 8 ASIA PACIFIC 3D CELL CULTURE MARKET, BY HANGING DROP MICROPLATES, 2019-2027 ($ MILLION)
  • FIGURE 9 ASIA PACIFIC 3D CELL CULTURE MARKET, BY SPHEROID MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA) COATING, 2019-2027 ($ MILLION)
  • FIGURE 10 ASIA PACIFIC 3D CELL CULTURE MARKET, BY MICROFLUIDIC 3D CELL CULTURE, 2019-2027 ($ MILLION)
  • FIGURE 11 ASIA PACIFIC 3D CELL CULTURE MARKET, BY MAGNETIC LEVITATIONS & 3D BIOPRINTING, 2019-2027 ($ MILLION)
  • FIGURE 12 ASIA PACIFIC 3D CELL CULTURE MARKET, BY 3D BIOREACTORS, 2019-2027 ($ MILLION)
  • FIGURE 13 ASIA PACIFIC 3D CELL CULTURE MARKET SHARE, BY APPLICATION, 2018 & 2027 (%)
  • FIGURE 14 ASIA PACIFIC 3D CELL CULTURE MARKET, BY CANCER, 2019-2027 ($ MILLION)
  • FIGURE 15 ASIA PACIFIC 3D CELL CULTURE MARKET, BY TISSUE ENGINEERING & IMMUNOHISTOCHEMISTRY, 2019-2027 ($ MILLION)
  • FIGURE 16 ASIA PACIFIC 3D CELL CULTURE MARKET, BY DRUG DEVELOPMENT, 2019-2027 ($ MILLION)
  • FIGURE 17 ASIA PACIFIC 3D CELL CULTURE MARKET, BY STEM CELL RESEARCH, 2019-2027 ($ MILLION)
  • FIGURE 18 ASIA PACIFIC 3D CELL CULTURE MARKET, BY OTHER APPLICATION, 2019-2027 ($ MILLION)
  • FIGURE 19 ASIA PACIFIC 3D CELL CULTURE MARKET SHARE, BY END-USER, 2018 & 2027 (%)
  • FIGURE 20 ASIA PACIFIC 3D CELL CULTURE MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL ORGANIZATIONS, 2019-2027 ($ MILLION)
  • FIGURE 21 ASIA PACIFIC 3D CELL CULTURE MARKET, BY RESEARCH LABORATORIES AND INSTITUTES, 2019-2027 ($ MILLION)
  • FIGURE 22 ASIA PACIFIC 3D CELL CULTURE MARKET, BY HOSPITALS AND DIAGNOSTIC CENTERS, 2019-2027 ($ MILLION)
  • FIGURE 23 ASIA PACIFIC 3D CELL CULTURE MARKET, BY OTHER END USER, 2019-2027 ($ MILLION)
  • FIGURE 24 ASIA PACIFIC 3D CELL CULTURE MARKET SHARE, BY COMPONENT, 2018 & 2027 (%)
  • FIGURE 25 ASIA PACIFIC 3D CELL CULTURE MARKET, BY MEDIA, 2019-2027 ($ MILLION)
  • FIGURE 26 ASIA PACIFIC 3D CELL CULTURE MARKET, BY REAGENTS AND CONSUMABLES, 2019-2027 ($ MILLION)
  • FIGURE 27 PORTER'S FIVE FORCE MODEL
  • FIGURE 28 JAPAN 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
  • FIGURE 29 CHINA 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
  • FIGURE 30 INDIA 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
  • FIGURE 31 AUSTRALIA 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
  • FIGURE 32 SOUTH KOREA 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
  • FIGURE 33 REST OF ASIA PACIFIC 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
Back to Top